Novartis is considering selling part of its radiopharmaceuticals company Advanced Accelerator Applications, Dinesh Nair of Bloomberg reports, citing people with knowledge of the matter said. Novartis is in the early stages of exploring a sale of some of AAA’s diagnostic imaging assets, sources told Bloomberg. AAA makes radioactive drugs used to treat diseases including cancer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVS:
- Novartis (NYSE:NVS) Completes its Generic Pharmaceutical Unit’s Spinoff
- Novartis says Phase 3 APPLAUSE-IgAN study met interim analysis primary endpoint
- Novartis completes divestment of ‘front of eye’ ophthalmology assets
- Bausch + Lomb completes acquisition of Xiidra from Novartis
- Molecular Templates appoints Maurizio Voi to chief medical officer